Plasma infusion from young APOE3 homozygotes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Plasma infusion from young APOE3 homozygotes, covering 2024-12-31 to 2024-12-31. Get the full timeline:
Most recent: Clinical Trial Update: Plasmapheresis Versus Plasma Infusion from Young APOE3 Homozygotes Into MCI APOE4 Homozygotes to Slow Disease Progression [Phase 1]